BRD4 and nut midline carcinoma: We next investigated the functionality of Fi-dBET6 NPs in vitro using a patient-derived model of NUT midline carcinoma (NMC), a rare and aggressive squamous cell epithelial cancer driven by the BRD4-NUT fusion oncoprotein (36, 37).